Skip to content

Medical-device intelligence

QEA: Brain Injury Adjunctive Interpretive Oculomotor Assessment Aid

FDA product code QEA: Brain Injury Adjunctive Interpretive Oculomotor Assessment Aid. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
QEA
FDA device name
Brain Injury Adjunctive Interpretive Oculomotor Assessment Aid
Device class
2
Regulation number
882.1455
Medical specialty
Neurology
Review panel
NE

FDA definition

A traumatic brain injury eye movement assessment aid is a prescription device that uses a patient’s tracked eye movements to provide an interpretation of the functional condition of the patient’s brain. This device is an assessment aid that is not intended for standalone detection or diagnostic purposes.
Explore neurology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

6 clearance records and 2 recall records in the covered releases, across 4 source company names and 1 product codes. Dated history runs from Apr 16, 2019 to Jun 5, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202610
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

8 matching records
Device / recordCompany in FDA recordSourceSource date
EyeBOX SNAPK254086 · QEAOculogica, Inc.510(k)Jun 5, 2026FDA decision date
NeuroSync EYE-SYNC containing Pico Neo 2 Headsets. Each unit consists of a Pico Neo 2 headset with embedded sensors, a paired Android tablet, and…Z-2114-2025 · QEANeuroSync, Inc.RecallJul 11, 2025FDA classification date
EyeBOX EBX-4.1K242116 · QEAOculogica, Inc.510(k)Apr 4, 2025FDA decision date
EyeBOX (Model EBX-4)K212310 · QEAOculogica, Inc.510(k)Dec 22, 2021FDA decision date
EYE-SYNCK202927 · QEASyncthink, Inc.510(k)Oct 2, 2021FDA decision date
EyeBOXK201841 · QEAOculogica, Inc.510(k)Sep 6, 2020FDA decision date
EyeBOX Model OCL 02Z-2398-2019 · QEAOCULOGICARecallAug 28, 2019FDA record creation date
EyeBOXK191183 · QEAOculogica, Inc.510(k)Jul 31, 2019FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗